期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

尿动力学在前列腺增生诊疗中的策略及其理论支撑 被引量：12

The Applications and Theoretical Basis of Urodynamic Studies in BPH
原文传递
导出
摘要 BPH患者的梗阻性和刺激性下尿路症状多种多样.缺乏特异性。尿动力学检查对BPH患者确定膀胱出口梗阻部位及程度、评估逼尿肌功能状态、预测手术疗效和并发症、术后评价疗效及分析并发症的原因均有重要的应用价值,对于合理选择BPH治疗策略的参考作用不可替代。 The obstructive and irratitive lower urinary tract symptoms of BPH are variable, lacking of specificity. Urodynamic studies could confirm the severity and position of bladder outlet obstruction（BOO）, evaluate the function of detrusor,predict the curative effects of surgery and analyze the causes of complications postoperatively. The valuable and clear information could be provided to choose the reasonable and suitable therapy of BPH by this irreplaceable tool.
作者 王东文 原小斌
机构地区 山西医科大学第一医院泌尿外科 山西省中西医结合医院泌尿外科
出处 《临床泌尿外科杂志》 北大核心 2011年第2期81-83,共3页 Journal of Clinical Urology
关键词 尿动力学检查 前列腺增生 理论支撑 urodynamic benign prostatic hyperplasia theoretical basis
分类号 R697 [医药卫生—泌尿科学]
  • 相关文献

参考文献11

二级参考文献39

  • 1龚志强,黄小平.前列腺增生症手术后并发膀胱颈部梗阻的腔内手术治疗[J].美国中华临床医学杂志,2005,7(2):149-150. 被引量：1
  • 2Christensen M, Bendix H J, Rasmussen P, et al. Doxazosin treatment in patients with prostatic obstruction. Scand J Urol Nephrol, 1993,27(1):39--44.
  • 3Chapple C. Selective alpha l-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience. Eur Urol,1996,29( 1 ) : 129-144.
  • 4Kirby RS. A randomized, double-blind crossover study of tamsulosin and controlled-release doxazosin in patients with benign prostatic hyperplasia. BJU International, 2003,91 ( 1 ) :41--44.
  • 5Chang M, Vsshi V, Puente J, et al. Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system(GITS) formation. BrJ Clin Pharmacol, 1999,48(4) :678-687.
  • 6Kirby RS, Anderson M, Gratzke P, et al. A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastroin-testinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia. BJU International, 2001, 87( 3 ) : 192-200.
  • 7Herbert L, Steven A, Kaplan IK, et al. Doxazosin for benign prostatic hyperplasia:long-term efficacy and safety in hypertensive and normotensive patients. J Urol, 1997,157 (2) : 525-530.
  • 8De Rose AF, Carmignani G, Corbu C, et al. Observatoinal multicentric trial performed with doxazosin : evaluation of sexual effects on patients with diagnosed benign prostatic hyperplasia. Urol lnt, 2002,68(2) :95-98.
  • 9Kyprianou N. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance. J Urol, 2003, 169 (4):1520-1525.
  • 10邓春华，中华泌尿外科杂志，1997年，18卷，116页

共引文献103

同被引文献123

  • 1廖新红.经直肠超声检测在前列腺增生症及前列腺癌诊断中的应用[J].广西医科大学学报,2010,27(6):969-971. 被引量：3
  • 2许哲,杨卫民,李光昭,李星洪.良性前列腺增生症患者残余尿量与腺体体积的临床价值研究[J].中国综合临床,2006,22(3):256-257. 被引量：6
  • 3Juliao AA, Plata M, Kazzazi A, et al. American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy : revisited. Curr Opin Urol, 2012,22; 34-39.
  • 4Chin HY,Lin KC , Chiang CH,et al. Combination of baclofen and antimuscarinics to reduce voiding difficulty in treating women with overactive bladders. Clin Exp Obstet Gynecol, 2012,39: 171-174.
  • 5Kantartzis K, Shepherd J. Sacral neuromodulation and intravesical botulinum toxin for refractory overactive bladder. Curr OpinObstet Gynecol, 2012 , 24: 331-336.
  • 6Timms BG, Hofkamp LE. Prostate development and growth in benign prostatic hyperplasia. Differentiation,2011 , 82 (4-5): 173-183.
  • 7Gabuev A, Oeike M. Latest trends and recommendations on epidemiology ,diagnosis,and treatment of benign prostatic hyperplasia (BPH). Aktuelle Urol, 2011,42: 167-178.
  • 8Shin TJ, Kim Cl, Park CH, et al. Alpha-blocker monotherapy and alpha-blocker plus 5 -alpha-reductase inhibitor combination treatment in benign prostatic hyperplasia : 10 years' long-term results. Korean J Urol, 2012,53: 248-252.
  • 9Elterman DS, Barkin J,Kaplan SA. Optimizing the management of benign prostatic hyperplasia. Ther Adv Urol, 2012,4 : 77-83.
  • 10McConnell JD,Roehrborn CG, Bautista OM,et al. The longterm effect of doxazosin, finasteride,and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med, 2003, 349: 2387-2398.

引证文献12

二级引证文献61

临床泌尿外科杂志
2011年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部